Author:
Nishihara Mitsuhiro,Hiura Yuto,Kawaguchi Naohiro,Takahashi Junzo,Asahi Satoru
Publisher
Japanese Society for the Study of Xenobiotics
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology
Reference36 articles.
1. Metabolic fate of sipoglitazar, a novel oral PPAR agonist with activities for PPAR-γ, -α and -δ, in rats and monkeys and comparison with humans in vitro;Nishihara;Drug Metab. Pharmacokinet.,2012
2. An unusual metabolic pathway of sipoglitazar, a novel anti-diabetic agent: Cytochrome P450-catalyzed oxidation of sipoglitazar acyl glucuronide;Nishihara;Drug Metab. Dispos.,2012
3. Evaluation of the impact of UGT polymorphism on the pharmacokinetics and pharmacodynamics of the novel PPAR agonist, sipoglitazar;Stringer;J. Clin. Pharmacol.,2013
4. The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent;Stringer;Eur. J. Clin. Pharmacol.,2013
5. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily;Mackenzie;Pharmacogenet. Genomics,2005
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献